Borealis Biosciences, Inc. | LinkedIn (original) (raw)

About us

Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.

Industry

Biotechnology Research

Company size

11-50 employees

Type

Privately Held

Founded

2024

Employees at Borealis Biosciences, Inc.

Updates

Join now to see what you are missing

Join now

Similar pages

Funding